Trinity Biotech Investment Limited, priced a public offering of $100 Million Senior Notes due on 2045.
The net proceeds would be used for future acquisitions and general business purpose.
View the full release here.
Trinity Biotech Investment Limited, priced a public offering of $100 Million Senior Notes due on 2045.
The net proceeds would be used for future acquisitions and general business purpose.
View the full release here.